GGrantIndex
← Leaderboards

Texas Tech University Health Scis Center

Lubbock, TX

Compare ↔
$235,765,393
Total funding
301
Grants

Funding over time

peak $14.5M · FY2005–25
$20M$15M$10M$5M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$235,206,769 · 297
CDC$558,624 · 3
AHRQ$0 · 1

By mechanism

R01$163,256,141 · 137
U01$18,108,821 · 7
R21$15,453,641 · 49
R15$7,943,645 · 24
P01$4,843,743 · 9
R03$4,361,320 · 34

Investigators at Texas Tech University Health Scis Center

Investigator-initiatedAll funding

InvestigatorsiAttributed = a PI's even-split share of each grant — a $1M grant with 2 PIs counts $500K each.
Exposure= the full size of every grant they're on ($1M each).

Rising Stars

First grant in the last 5 yrs

1Magdalena Karbowniczek$1,392,3811 gr2Petar Grozdanov$310,0001 gr

Emerging Leaders

6–10 yrs in

1Andrey L Karamyshev$1,583,0983 gr2Yangzom Doma Bhutia$1,196,2892 gr3Vardan T. Karamyan$1,187,1611 gr4Subodh Kumar$869,1161 gr5Anna Marie Eiring$480,0001 gr6Devin B Lowe$453,0791 gr7Maria Manczak$420,7501 gr8Laurence Michael Wood$376,7761 gr

All-Time

Most funded here, all years

1Sandor Gyorke$18,885,8664 gr2Kumuda C Das$12,717,5908 gr3Volker Neugebauer$12,534,9976 gr4Jane Yu$8,820,0518 gr5Thomas J Abbruscato$7,448,9166 gr6Charles Patrick Reynolds$7,341,7838 gr7Fakhrul Ahsan$7,151,9986 gr8Afzal A Siddiqui$5,992,4305 gr

Largest grants

Optical Technologies and Molecular Imaging for Cervical Neoplasia$2,469,576
P01 · FY2012 · CA
Optical Technologies and Molecular Imaging for Cervical Neoplasia$2,374,167
P01 · FY2013 · CA
MicroRNA Mouse Models and Alzheimer’s Disease$1,862,337
RF1 · FY2022 · AG
Medication Development for the Treatment of Alcohol Use Disorder$1,521,805
U01 · FY2020 · AA
Medication Development for the Treatment of Alcohol Use Disorder$1,486,106
U01 · FY2021 · AA
Medication Development for the Treatment of Alcohol Use Disorder$1,462,937
U01 · FY2022 · AA
Medication Development for the Treatment of Alcohol Use Disorder$1,401,264
U01 · FY2023 · AA
Medication Development for the Treatment of Alcohol Use Disorder$1,379,570
U01 · FY2024 · AA
BROAD-SPECTRUM RNAi THERAPEUTICS FOR FLAVIVIRAL ENCEPHALITIS$874,476
U01 · FY2009 · AI
BROAD-SPECTRUM RNAi THERAPEUTICS FOR FLAVIVIRAL ENCEPHALITIS$849,005
U01 · FY2008 · AI
Chemically modified minocycline for treatment of alcohol use disorder$824,590
U01 · FY2018 · AA
Chemically modified minocycline for treatment of alcohol use disorder$798,758
U01 · FY2019 · AA
Investigate the role of extracellular vesicles in promoting the progression of pulmonary lymphangioleiomyomatosis$718,036
R01 · FY2022 · HL
Investigate the role of extracellular vesicles in promoting the progression of pulmonary lymphangioleiomyomatosis$699,460
R01 · FY2023 · HL
Small Molecules as Therapeutic Targets for Alzheimer's Disease$699,245
R56 · FY2019 · AG
Role of HIV gp120 and Nef in Transcriptome Dysregulation and Pulmonary Vascular Remodeling$697,518
R01 · FY2024 · HL
Investigate the role of extracellular vesicles in promoting the progression of pulmonary lymphangioleiomyomatosis$687,328
R01 · FY2025 · HL
Role of HIV gp120 and Nef in Transcriptome Dysregulation and Pulmonary Vascular Remodeling$682,218
R01 · FY2025 · HL
Investigate the role of extracellular vesicles in promoting the progression of pulmonary lymphangioleiomyomatosis$679,938
R01 · FY2024 · HL
Population Based Mapping of Schizophrenia Genes$678,075
R01 · FY2010 · MH